Talphera (TLPH) Shares Outstanding (Weighted Average) (2010 - 2026)

Talphera (TLPH) recorded quarterly Shares Outstanding (Weighted Average) of $69.8 million in Q1 2026, up 77.58% quarter-over-quarter from $39.3 million in Q4 2025, and up 165.8% on a YoY basis from $26.3 million in Q1 2025.

Talphera (TLPH) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Talphera's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $69.8 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 165.8% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $69.8 million (up 165.8% YoY), while the FY2025 annual figure was $42.4 million, up 43.89% from the prior year.
  • Shares Outstanding (Weighted Average) was $69.8 million for Q1 2026 at Talphera, up from $39.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $145.6 million in Q1 2022 to a low of $5.2 million in Q1 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $33.8 million across 5 years, with a median of $29.5 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) surged 3234.82% in 2022, then tumbled 96.43% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.5 million in 2022, then slipped by 26.44% to $21.7 million in 2023, then soared by 35.94% to $29.5 million in 2024, then soared by 33.4% to $39.3 million in 2025, then soared by 77.58% to $69.8 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $69.8 million (Q1 2026), $39.3 million (Q4 2025), and $40.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Talphera 56.42 Mn 56.42 Mn - 69.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 69.82 Mn
Dec 31, 2025 39.32 Mn
Sep 30, 2025 40.32 Mn
Jun 30, 2025 34.53 Mn
Mar 31, 2025 26.27 Mn
Dec 31, 2024 29.47 Mn
Sep 30, 2024 29.47 Mn
Jun 30, 2024 26.20 Mn
Mar 31, 2024 29.47 Mn
Dec 31, 2023 21.68 Mn
Sep 30, 2023 21.68 Mn
Jun 30, 2023 10.92 Mn
Mar 31, 2023 5.19 Mn
Dec 31, 2022 29.47 Mn
Sep 30, 2022 7.34 Mn
Jun 30, 2022 7.36 Mn
Mar 31, 2022 145.62 Mn
Dec 31, 2021 883,833.00
Sep 30, 2021 5.86 Mn
Jun 30, 2021 119.12 Mn